Vexiau P, Husson C, Chivot M, Brerault J L, Fiet J, Julien R, Villette J M, Hardy N, Cathelineau G
Department of Endocrinology and Diabetology, Hôpital Saint-Louis, Paris, France.
J Invest Dermatol. 1990 Mar;94(3):279-83. doi: 10.1111/1523-1747.ep12874121.
Acne is known to be one of the features of hyperandrogenism. The aim of the present work was to study women with persistent acne and without other evidence of hyperandrogenism, such as hirsutism, alopecia, or irregular menses. Among 87 female patients with acne and/or hirsutism, we defined three groups: group 1 (n = 29), patients having treatment-resistant acne without menstrual disturbance, alopecia, or hirsutism; group 2 (n = 27), patients with acne and hirsutism; and group 3 (n = 31), patients with hirsutism alone. Clinical chemistry criteria for hyperandrogenism were based on elevated values of one or more of the following parameters: plasma testosterone, delta-4-androstenedione, dehydroepiandrosterone, urinary 5 alpha-androstane 3 alpha-17 beta-diol, and 17-ketosteroids (with chromatography). Plasma and urine samples were drawn between the 18th and 25th days of the cycle. Among group 1 patients, we found 25 subjects (86%) with hyperandrogenism, according to these laboratory criteria. The etiologies were: polycystic ovary syndrome (36%), adrenal hypersecretion (40%, of which 12% showed secondary polycystic ovaries), isolated increase in 5 alpha-androstane 3 alpha-17 beta-diol (20%), and hyperandrogenism without diagnosis (4%). The parameters were found to be more elevated in these patients than in a control group of 30 normal volunteer women. In groups 2 and 3, the findings were essentially the same as in group 1, except for increased levels of testosterone and the testosterone/SHBG ratio. Furthermore, it was evident that persistent acne may be an isolated sign of hyperandrogenism.
痤疮是高雄激素血症的特征之一。本研究的目的是研究患有持续性痤疮且无其他高雄激素血症证据(如多毛症、脱发或月经不调)的女性。在87例患有痤疮和/或多毛症的女性患者中,我们定义了三组:第1组(n = 29),患有治疗抵抗性痤疮且无月经紊乱、脱发或多毛症的患者;第2组(n = 27),患有痤疮和多毛症的患者;第3组(n = 31),仅患有多毛症的患者。高雄激素血症的临床化学标准基于以下一个或多个参数值升高:血浆睾酮、δ-4-雄烯二酮、脱氢表雄酮、尿5α-雄烷3α-17β-二醇和17-酮类固醇(采用色谱法)。在月经周期的第18至25天采集血浆和尿液样本。根据这些实验室标准,在第1组患者中,我们发现25名受试者(86%)存在高雄激素血症。病因包括:多囊卵巢综合征(36%)、肾上腺分泌过多(40%,其中12%表现为继发性多囊卵巢)、5α-雄烷3α-17β-二醇单独升高(20%)以及未明确诊断的高雄激素血症(4%)。这些患者的参数值高于30名正常志愿者女性组成的对照组。在第2组和第3组中,除了睾酮水平和睾酮/性激素结合球蛋白比值升高外,结果与第1组基本相同。此外,明显的是,持续性痤疮可能是高雄激素血症的孤立体征。